Clozapine
Open Access
- 1 October 1991
- journal article
- Published by Royal College of Psychiatrists in Psychiatric Bulletin
- Vol. 15 (10) , 617
- https://doi.org/10.1192/pb.15.10.617
Abstract
On several occasions in the last ten years, when interviewed by a market researcher about future developments in the treatment of schizophrenia, we have said that the biggest problem in the drug management of schizophrenia is compliance. We believed that if drug companies could manufacture an injectable neuroleptic lasting six months, then many of our problems would be over. Compared with this, the benefits of a new neuroleptic preparation appeared to be trivial.Keywords
This publication has 0 references indexed in Scilit: